Biocure Technology Inc. CUREX
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | 134.50K | 45.60K | 172.00K | 146.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 134.50K | 45.60K | 172.00K | 146.90K |
| Operating Income | -- | -134.50K | -45.60K | -172.00K | -146.90K |
| Income Before Tax | -- | -879.80K | -74.20K | -203.60K | -176.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -0.88 | -0.07 | -0.20 | -0.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -879.80K | -74.20K | -203.60K | -176.30K |
| EBIT | -- | -134.50K | -45.60K | -172.00K | -146.90K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -0.04 | 0.00 | -0.02 | -0.02 |
| Normalized Basic EPS | -- | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | -- | -0.04 | 0.00 | -0.02 | -0.02 |
| Normalized Diluted EPS | -- | -0.01 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | -- | 68.70M | 58.93M | 49.12M | 114.62M |
| Average Diluted Shares Outstanding | -- | 68.70M | 58.93M | 49.12M | 114.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |